# BioReason-Pro RL Review: ral2 (SCHPO)

Source: ral2-deep-research-bioreason-rl.md

- **Correctness**: 2/5
- **Completeness**: 2/5

BioReason correctly identifies the Kelch-type beta-propeller (IPR015915) and SKP1/BTB/POZ domain superfamily (IPR011333) architecture and reasonably infers a protein-protein interaction adaptor function. The cytoplasmic/ER localization is broadly consistent with experimental data (HDA from PMID:16823372 shows ER localization).

However, BioReason constructs an entirely fabricated biological role. It proposes that ral2 is a **ubiquitin ligase substrate adaptor** bridging substrates to a cullin-RING E3 ligase for ubiquitination and proteolysis. There is zero evidence for this in the literature. The curated review establishes that ral2 is a **signaling adaptor upstream of Ras1** in the Ras1-Scd1-Cdc42 signaling pathway, required for mating/conjugation, pheromone response, and maintenance of elongated cell morphology. This is supported by genetic evidence (PMID:2586528, PMID:3071741) showing that ral2 mutants phenocopy ras1 deletion and activated Ras1 rescues ral2 mutants.

The curated review also identifies a critical curation problem: ral2 has been incorrectly assigned to PANTHER family PTHR43503 (Peroxiredoxin family, Prx6 subfamily), leading to IBA annotations for peroxidase activity, cell redox homeostasis, and cellular oxidant detoxification -- all of which are wrong for a kelch repeat protein. BioReason does not fall into this particular trap (it correctly ignores peroxidase function), but it invents a different wrong function (ubiquitin ligase adaptor).

The InterPro-derived GO terms listed by BioReason include "molecular adaptor activity" (GO:0060090), "signal transduction involved in positive regulation of conjugation with cellular fusion" (GO:0032005), and "regulation of conjugation with cellular fusion" (GO:0031137) -- all of which match the curated review. Yet BioReason's reasoning narrative completely ignores these specific terms in favor of a generic ubiquitination hypothesis derived from domain architecture alone.

BioReason misses: the Ras1 signaling pathway, mating/conjugation function, pheromone response, cell morphology maintenance, the genetic epistasis data, and the fact that the molecular function remains uncharacterized (ND annotation is appropriate).

Key failure modes: **fold-bias** (BTB/Kelch = ubiquitin ligase adaptor, a common but incorrect assumption); ignoring organism-specific GO term annotations that were available in its own output; fabricating a biological role from domain architecture without organism-specific evidence.
